US chip supplier Nvidia announced on Thursday, April 16, Chinese authorities had approved its US$6.9 billion acquisition of Israeli chip designer Mellanox Technologies, overcoming the last obstacle for the deal announced over a year earlier.
Many acquisitions between US and international companies with significant operations in China have faced challenges in securing approval from the country’s regulator due to a bitter trade war between the two largest economies of the world that started in January, 2018.
Two years ago, US chipmaker Qualcomm had to walk away from a US$44 billion deal to buy NXP Semiconductors after failing to secure Chinese regulatory approval.
Nvidia, known for its powerful gaming graphics chips, wants to bolster its data center and artificial intelligence business through the Mellanox takeover, its biggest deal, to better compete with rival Intel.
US and EU antitrust authorities have already given their approval for the deal, which is expected to close before April 27, 2020.
Full Content: Yahoo
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan